These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Assessing balance in measured baseline covariates when using many-to-one matching on the propensity-score. Austin PC. Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1218-25. PubMed ID: 18972455 [Abstract] [Full Text] [Related]
3. Reduced disability at five years with early treatment of inflammatory polyarthritis: results from a large observational cohort, using propensity models to adjust for disease severity. Wiles NJ, Lunt M, Barrett EM, Bukhari M, Silman AJ, Symmons DP, Dunn G. Arthritis Rheum; 2001 May; 44(5):1033-42. PubMed ID: 11352234 [Abstract] [Full Text] [Related]
4. Goodness-of-fit diagnostics for the propensity score model when estimating treatment effects using covariate adjustment with the propensity score. Austin PC. Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1202-17. PubMed ID: 18972454 [Abstract] [Full Text] [Related]
5. Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study. Austin PC, Grootendorst P, Normand SL, Anderson GM. Stat Med; 2007 Feb 20; 26(4):754-68. PubMed ID: 16783757 [Abstract] [Full Text] [Related]
10. The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies. Austin PC. Med Decis Making; 2009 Feb 20; 29(6):661-77. PubMed ID: 19684288 [Abstract] [Full Text] [Related]
11. Propensity score estimation with boosted regression for evaluating causal effects in observational studies. McCaffrey DF, Ridgeway G, Morral AR. Psychol Methods; 2004 Dec 20; 9(4):403-25. PubMed ID: 15598095 [Abstract] [Full Text] [Related]
12. Addressing the issue of channeling bias in observational studies with propensity scores analysis. Lobo FS, Wagner S, Gross CR, Schommer JC. Res Social Adm Pharm; 2006 Mar 20; 2(1):143-51. PubMed ID: 17138506 [Abstract] [Full Text] [Related]
14. Using propensity scores subclassification to estimate effects of longitudinal treatments: an example using a new diabetes medication. Segal JB, Griswold M, Achy-Brou A, Herbert R, Bass EB, Dy SM, Millman AE, Wu AW, Frangakis CE. Med Care; 2007 Oct 20; 45(10 Supl 2):S149-57. PubMed ID: 17909374 [Abstract] [Full Text] [Related]
16. Propensity score methods and their application in nephrology research. Barnieh L, James MT, Zhang J, Hemmelgarn BR. J Nephrol; 2011 Oct 20; 24(3):256-62. PubMed ID: 21404223 [Abstract] [Full Text] [Related]
17. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Austin PC. Stat Med; 2008 May 30; 27(12):2037-49. PubMed ID: 18038446 [Abstract] [Full Text] [Related]
18. Methods to assess intended effects of drug treatment in observational studies are reviewed. Klungel OH, Martens EP, Psaty BM, Grobbee DE, Sullivan SD, Stricker BH, Leufkens HG, de Boer A. J Clin Epidemiol; 2004 Dec 30; 57(12):1223-31. PubMed ID: 15617947 [Abstract] [Full Text] [Related]
19. Weaknesses of goodness-of-fit tests for evaluating propensity score models: the case of the omitted confounder. Weitzen S, Lapane KL, Toledano AY, Hume AL, Mor V. Pharmacoepidemiol Drug Saf; 2005 Apr 30; 14(4):227-38. PubMed ID: 15386700 [Abstract] [Full Text] [Related]
20. Performance of disease risk scores, propensity scores, and traditional multivariable outcome regression in the presence of multiple confounders. Arbogast PG, Ray WA. Am J Epidemiol; 2011 Sep 01; 174(5):613-20. PubMed ID: 21749976 [Abstract] [Full Text] [Related] Page: [Next] [New Search]